JPH027922B2 - - Google Patents
Info
- Publication number
- JPH027922B2 JPH027922B2 JP54125214A JP12521479A JPH027922B2 JP H027922 B2 JPH027922 B2 JP H027922B2 JP 54125214 A JP54125214 A JP 54125214A JP 12521479 A JP12521479 A JP 12521479A JP H027922 B2 JPH027922 B2 JP H027922B2
- Authority
- JP
- Japan
- Prior art keywords
- weight
- filler
- oxide
- radiopaque
- barium
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 239000000203 mixture Substances 0.000 claims description 43
- 239000000945 filler Substances 0.000 claims description 36
- 239000002131 composite material Substances 0.000 claims description 21
- ZCUFMDLYAMJYST-UHFFFAOYSA-N thorium dioxide Chemical compound O=[Th]=O ZCUFMDLYAMJYST-UHFFFAOYSA-N 0.000 claims description 21
- 239000011230 binding agent Substances 0.000 claims description 17
- 239000002245 particle Substances 0.000 claims description 12
- 229910003452 thorium oxide Inorganic materials 0.000 claims description 10
- BPUBBGLMJRNUCC-UHFFFAOYSA-N oxygen(2-);tantalum(5+) Chemical compound [O-2].[O-2].[O-2].[O-2].[O-2].[Ta+5].[Ta+5] BPUBBGLMJRNUCC-UHFFFAOYSA-N 0.000 claims description 8
- 229920005989 resin Polymers 0.000 claims description 6
- 239000011347 resin Substances 0.000 claims description 5
- 239000000919 ceramic Substances 0.000 claims description 4
- 239000007788 liquid Substances 0.000 claims description 4
- 238000002386 leaching Methods 0.000 claims description 3
- PBCFLUZVCVVTBY-UHFFFAOYSA-N tantalum pentoxide Inorganic materials O=[Ta](=O)O[Ta](=O)=O PBCFLUZVCVVTBY-UHFFFAOYSA-N 0.000 claims description 3
- 239000011521 glass Substances 0.000 description 20
- 229910052788 barium Inorganic materials 0.000 description 19
- DSAJWYNOEDNPEQ-UHFFFAOYSA-N barium atom Chemical compound [Ba] DSAJWYNOEDNPEQ-UHFFFAOYSA-N 0.000 description 19
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 12
- 239000000178 monomer Substances 0.000 description 9
- MRELNEQAGSRDBK-UHFFFAOYSA-N lanthanum oxide Inorganic materials [O-2].[O-2].[O-2].[La+3].[La+3] MRELNEQAGSRDBK-UHFFFAOYSA-N 0.000 description 8
- 239000000463 material Substances 0.000 description 8
- 239000003054 catalyst Substances 0.000 description 7
- 239000011256 inorganic filler Substances 0.000 description 7
- 229910003475 inorganic filler Inorganic materials 0.000 description 7
- 239000002952 polymeric resin Substances 0.000 description 6
- 229920003002 synthetic resin Polymers 0.000 description 6
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 5
- 238000010521 absorption reaction Methods 0.000 description 4
- ZSLUVFAKFWKJRC-IGMARMGPSA-N 232Th Chemical compound [232Th] ZSLUVFAKFWKJRC-IGMARMGPSA-N 0.000 description 3
- 239000006087 Silane Coupling Agent Substances 0.000 description 3
- 229910052776 Thorium Inorganic materials 0.000 description 3
- 238000007792 addition Methods 0.000 description 3
- QVQLCTNNEUAWMS-UHFFFAOYSA-N barium oxide Chemical compound [Ba]=O QVQLCTNNEUAWMS-UHFFFAOYSA-N 0.000 description 3
- 239000000805 composite resin Substances 0.000 description 3
- 239000002872 contrast media Substances 0.000 description 3
- 239000011350 dental composite resin Substances 0.000 description 3
- 239000004615 ingredient Substances 0.000 description 3
- 230000008439 repair process Effects 0.000 description 3
- 235000012239 silicon dioxide Nutrition 0.000 description 3
- 229910001936 tantalum oxide Inorganic materials 0.000 description 3
- 238000012360 testing method Methods 0.000 description 3
- USFZMSVCRYTOJT-UHFFFAOYSA-N Ammonium acetate Chemical compound N.CC(O)=O USFZMSVCRYTOJT-UHFFFAOYSA-N 0.000 description 2
- 239000005695 Ammonium acetate Substances 0.000 description 2
- UQSXHKLRYXJYBZ-UHFFFAOYSA-N Iron oxide Chemical compound [Fe]=O UQSXHKLRYXJYBZ-UHFFFAOYSA-N 0.000 description 2
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 description 2
- XLOMVQKBTHCTTD-UHFFFAOYSA-N Zinc monoxide Chemical compound [Zn]=O XLOMVQKBTHCTTD-UHFFFAOYSA-N 0.000 description 2
- MCMNRKCIXSYSNV-UHFFFAOYSA-N Zirconium dioxide Chemical compound O=[Zr]=O MCMNRKCIXSYSNV-UHFFFAOYSA-N 0.000 description 2
- FQNGWRSKYZLJDK-UHFFFAOYSA-N [Ca].[Ba] Chemical compound [Ca].[Ba] FQNGWRSKYZLJDK-UHFFFAOYSA-N 0.000 description 2
- 239000006096 absorbing agent Substances 0.000 description 2
- 229940043376 ammonium acetate Drugs 0.000 description 2
- 235000019257 ammonium acetate Nutrition 0.000 description 2
- 239000008346 aqueous phase Substances 0.000 description 2
- AYJRCSIUFZENHW-UHFFFAOYSA-L barium carbonate Chemical compound [Ba+2].[O-]C([O-])=O AYJRCSIUFZENHW-UHFFFAOYSA-L 0.000 description 2
- 229910052916 barium silicate Inorganic materials 0.000 description 2
- TZCXTZWJZNENPQ-UHFFFAOYSA-L barium sulfate Chemical compound [Ba+2].[O-]S([O-])(=O)=O TZCXTZWJZNENPQ-UHFFFAOYSA-L 0.000 description 2
- CJOBVZJTOIVNNF-UHFFFAOYSA-N cadmium sulfide Chemical compound [Cd]=S CJOBVZJTOIVNNF-UHFFFAOYSA-N 0.000 description 2
- 229910010293 ceramic material Inorganic materials 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 239000012153 distilled water Substances 0.000 description 2
- 238000000034 method Methods 0.000 description 2
- 239000000049 pigment Substances 0.000 description 2
- 238000006116 polymerization reaction Methods 0.000 description 2
- 239000010453 quartz Substances 0.000 description 2
- 230000005855 radiation Effects 0.000 description 2
- 239000000377 silicon dioxide Substances 0.000 description 2
- 239000003381 stabilizer Substances 0.000 description 2
- IATRAKWUXMZMIY-UHFFFAOYSA-N strontium oxide Chemical compound [O-2].[Sr+2] IATRAKWUXMZMIY-UHFFFAOYSA-N 0.000 description 2
- 229910052715 tantalum Inorganic materials 0.000 description 2
- GUVRBAGPIYLISA-UHFFFAOYSA-N tantalum atom Chemical compound [Ta] GUVRBAGPIYLISA-UHFFFAOYSA-N 0.000 description 2
- KQVYEDNFMJZQDM-UHFFFAOYSA-N (1,2-diacetyloxy-2-silylethenyl) acetate Chemical compound CC(=O)OC([SiH3])=C(OC(C)=O)OC(C)=O KQVYEDNFMJZQDM-UHFFFAOYSA-N 0.000 description 1
- FRIBMENBGGCKPD-UHFFFAOYSA-N 3-(2,3-dimethoxyphenyl)prop-2-enal Chemical compound COC1=CC=CC(C=CC=O)=C1OC FRIBMENBGGCKPD-UHFFFAOYSA-N 0.000 description 1
- XDLMVUHYZWKMMD-UHFFFAOYSA-N 3-trimethoxysilylpropyl 2-methylprop-2-enoate Chemical compound CO[Si](OC)(OC)CCCOC(=O)C(C)=C XDLMVUHYZWKMMD-UHFFFAOYSA-N 0.000 description 1
- SAPGBCWOQLHKKZ-UHFFFAOYSA-N 6-(2-methylprop-2-enoyloxy)hexyl 2-methylprop-2-enoate Chemical compound CC(=C)C(=O)OCCCCCCOC(=O)C(C)=C SAPGBCWOQLHKKZ-UHFFFAOYSA-N 0.000 description 1
- 229910018072 Al 2 O 3 Inorganic materials 0.000 description 1
- BVKZGUZCCUSVTD-UHFFFAOYSA-L Carbonate Chemical compound [O-]C([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-L 0.000 description 1
- KRHYYFGTRYWZRS-UHFFFAOYSA-N Fluorane Chemical group F KRHYYFGTRYWZRS-UHFFFAOYSA-N 0.000 description 1
- 229910021193 La 2 O 3 Inorganic materials 0.000 description 1
- 241000577415 Lanthus Species 0.000 description 1
- 229910018068 Li 2 O Inorganic materials 0.000 description 1
- IPCRBOOJBPETMF-UHFFFAOYSA-N N-acetylthiourea Chemical compound CC(=O)NC(N)=S IPCRBOOJBPETMF-UHFFFAOYSA-N 0.000 description 1
- AMFGWXWBFGVCKG-UHFFFAOYSA-N Panavia opaque Chemical compound C1=CC(OCC(O)COC(=O)C(=C)C)=CC=C1C(C)(C)C1=CC=C(OCC(O)COC(=O)C(C)=C)C=C1 AMFGWXWBFGVCKG-UHFFFAOYSA-N 0.000 description 1
- 229910004298 SiO 2 Inorganic materials 0.000 description 1
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 1
- 239000004809 Teflon Substances 0.000 description 1
- 229920006362 Teflon® Polymers 0.000 description 1
- 238000002441 X-ray diffraction Methods 0.000 description 1
- 239000012190 activator Substances 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 239000007900 aqueous suspension Substances 0.000 description 1
- 238000001479 atomic absorption spectroscopy Methods 0.000 description 1
- 229910001422 barium ion Inorganic materials 0.000 description 1
- 159000000009 barium salts Chemical class 0.000 description 1
- 239000011324 bead Substances 0.000 description 1
- 238000013329 compounding Methods 0.000 description 1
- 239000007822 coupling agent Substances 0.000 description 1
- 239000002178 crystalline material Substances 0.000 description 1
- 229910002026 crystalline silica Inorganic materials 0.000 description 1
- 210000003298 dental enamel Anatomy 0.000 description 1
- 239000003085 diluting agent Substances 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 239000000975 dye Substances 0.000 description 1
- KBQHZAAAGSGFKK-UHFFFAOYSA-N dysprosium atom Chemical compound [Dy] KBQHZAAAGSGFKK-UHFFFAOYSA-N 0.000 description 1
- 229910003440 dysprosium oxide Inorganic materials 0.000 description 1
- 238000010828 elution Methods 0.000 description 1
- 229910000174 eucryptite Inorganic materials 0.000 description 1
- 239000005350 fused silica glass Substances 0.000 description 1
- 239000002241 glass-ceramic Substances 0.000 description 1
- 229910052735 hafnium Inorganic materials 0.000 description 1
- VBJZVLUMGGDVMO-UHFFFAOYSA-N hafnium atom Chemical compound [Hf] VBJZVLUMGGDVMO-UHFFFAOYSA-N 0.000 description 1
- 239000003112 inhibitor Substances 0.000 description 1
- 239000003999 initiator Substances 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 239000010954 inorganic particle Substances 0.000 description 1
- 239000002198 insoluble material Substances 0.000 description 1
- 239000005351 kimble Substances 0.000 description 1
- 229910052747 lanthanoid Inorganic materials 0.000 description 1
- 150000002602 lanthanoids Chemical class 0.000 description 1
- 231100000053 low toxicity Toxicity 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 239000011159 matrix material Substances 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 239000006060 molten glass Substances 0.000 description 1
- 239000004570 mortar (masonry) Substances 0.000 description 1
- 231100000956 nontoxicity Toxicity 0.000 description 1
- 239000002667 nucleating agent Substances 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- KTUFCUMIWABKDW-UHFFFAOYSA-N oxo(oxolanthaniooxy)lanthanum Chemical compound O=[La]O[La]=O KTUFCUMIWABKDW-UHFFFAOYSA-N 0.000 description 1
- MMKQUGHLEMYQSG-UHFFFAOYSA-N oxygen(2-);praseodymium(3+) Chemical compound [O-2].[O-2].[O-2].[Pr+3].[Pr+3] MMKQUGHLEMYQSG-UHFFFAOYSA-N 0.000 description 1
- RVTZCBVAJQQJTK-UHFFFAOYSA-N oxygen(2-);zirconium(4+) Chemical compound [O-2].[O-2].[Zr+4] RVTZCBVAJQQJTK-UHFFFAOYSA-N 0.000 description 1
- 238000004806 packaging method and process Methods 0.000 description 1
- 239000012071 phase Substances 0.000 description 1
- 230000000704 physical effect Effects 0.000 description 1
- 239000011160 polymer matrix composite Substances 0.000 description 1
- 229920013657 polymer matrix composite Polymers 0.000 description 1
- 230000000379 polymerizing effect Effects 0.000 description 1
- 229910052573 porcelain Inorganic materials 0.000 description 1
- -1 praseodymium oxide Chemical compound 0.000 description 1
- 229910003447 praseodymium oxide Inorganic materials 0.000 description 1
- 239000001294 propane Substances 0.000 description 1
- 238000002601 radiography Methods 0.000 description 1
- 229910052761 rare earth metal Inorganic materials 0.000 description 1
- 239000011226 reinforced ceramic Substances 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 229910001954 samarium oxide Inorganic materials 0.000 description 1
- 229940075630 samarium oxide Drugs 0.000 description 1
- FKTOIHSPIPYAPE-UHFFFAOYSA-N samarium(iii) oxide Chemical compound [O-2].[O-2].[O-2].[Sm+3].[Sm+3] FKTOIHSPIPYAPE-UHFFFAOYSA-N 0.000 description 1
- 239000005368 silicate glass Substances 0.000 description 1
- 150000004760 silicates Chemical class 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 229910052712 strontium Inorganic materials 0.000 description 1
- CIOAGBVUUVVLOB-UHFFFAOYSA-N strontium atom Chemical compound [Sr] CIOAGBVUUVVLOB-UHFFFAOYSA-N 0.000 description 1
- 229910003451 terbium oxide Inorganic materials 0.000 description 1
- SCRZPWWVSXWCMC-UHFFFAOYSA-N terbium(iii) oxide Chemical compound [O-2].[O-2].[O-2].[Tb+3].[Tb+3] SCRZPWWVSXWCMC-UHFFFAOYSA-N 0.000 description 1
- SFKTYEXKZXBQRQ-UHFFFAOYSA-J thorium(4+);tetrahydroxide Chemical compound [OH-].[OH-].[OH-].[OH-].[Th+4] SFKTYEXKZXBQRQ-UHFFFAOYSA-J 0.000 description 1
- 239000004408 titanium dioxide Substances 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- GQIUQDDJKHLHTB-UHFFFAOYSA-N trichloro(ethenyl)silane Chemical compound Cl[Si](Cl)(Cl)C=C GQIUQDDJKHLHTB-UHFFFAOYSA-N 0.000 description 1
- HQYALQRYBUJWDH-UHFFFAOYSA-N trimethoxy(propyl)silane Chemical compound CCC[Si](OC)(OC)OC HQYALQRYBUJWDH-UHFFFAOYSA-N 0.000 description 1
- CIOXFKGQNIJXKF-UHFFFAOYSA-N tris(2-methoxyethoxy)silane Chemical compound COCCO[SiH](OCCOC)OCCOC CIOXFKGQNIJXKF-UHFFFAOYSA-N 0.000 description 1
- 239000005050 vinyl trichlorosilane Substances 0.000 description 1
- 239000011787 zinc oxide Substances 0.000 description 1
- 229910001928 zirconium oxide Inorganic materials 0.000 description 1
Landscapes
- Dental Preparations (AREA)
Description
本発明はX線不透過性充填剤組成物及び特にこ
のようなX線不透過性充填剤組成物を用いた歯補
綴組成物に関する。
粒状強化重合体母材複合材は歯補綴材、特に充
填及び切歯端補修、インレー等として広く用いら
れている。無機充填剤相は典型的には珪酸質材、
例えばシリカ、水晶、耐火性塩類、ガラスまたは
セラミツク材であつた。これらの強化重合体材料
は応々にして強度、着色、無毒性及び熱膨張率に
関して満足すべき結果を与えるが、これらの物質
は歯科診断に用いられているようなX線分析によ
り判別しにくいという欠点に悩まされている。
従つて、多くの試みがなされ、珪酸質充填剤の
一部または全てを置換するためにバリウム含有ガ
ラスが用いられた放射線不透過性歯科用組成物が
得られた。その例は米国特許第3808170号(S.
Rogers)、米国特許第3801344号、同第3826778
号、同第3911581号(いずれもE.Dietz)及び米国
特許第4032504号(Lee Rharmaceuticals)であ
る。しかしながら、充分な放射線不透過性を達成
するために充分なバリウムを含有するように処方
したガラス充填剤は含水環境中、特に口腔内環境
中でガラスが相当可溶性であり、バリウムイオン
がガラスから滲出するという欠点に悩まされる。
この形態のバリウムが毒性危険を呈することは非
常に強い裏付けがある。
最近バリウムガラスの代りに他の放射線不透過
性充填剤材料を用いる試みがなされた。これらの
試みには例えば珪酸質充填剤と組合せて炭酸バリ
ウム及び硫酸バリウムのようなかなり不溶性のバ
リウム塩を用いることが含まれていた。しかしな
がら、これらの強化セラミツク材料は得られた複
合材の機械的強度という点で不満足であつた。
米国特許第3959212号(Rockett他)は微細晶
質バリウム含有珪酸塩及び特に結晶形の珪酸カル
シウムバリウムを、重合性結合剤、結合剤を重合
させるための触媒系及び少なくともその一部が放
射線不透過性晶質珪酸カルシウムバリウムから形
成された微細無機充填剤を含有する直接充填式歯
科用複合材中に用いることを教示している。この
組成物は無機充填剤のバリウム成分の溶解性に関
しある程度の改善を与えるが、これはバリウム成
分の滲出性及び複合材料の放射線不透過性に関し
て完全に満足できるものではない。
また、例えば米国特許第3971754号(A.
Jurecic)及び米国特許第3973972号及び同第
4017454号(いずれもg.Muller)において高原子
量の原子の高いX線吸収能力を利用することが提
案された。例えば、米国特許第3971754号は酸化
物、炭酸塩または弗化物の形態のランタス、スト
ロンチウム、及びタンタルにわずかに添加された
ハフニウムから選択されたX線吸収性原子を用い
たセラミツク充填剤組成物を教示している。この
特許によれば、X線吸収性原子の化合物は全溶融
ガラス組成物の約5〜60%、好ましくは25〜40%
を占め、この組成物は次いで補修母材中に混入さ
れる。
米国特許第3973972号及び同第4017454号は低い
膨張率、高いX線吸収能を有し、歯科用充填剤組
成物中に用いるのに適した透明無色ガラスセラミ
ツクを開示しており、このガラスセラミツク組成
物は主としてSiO2,Al2O3,Li2O,P2O5及び
ZrO2である他のガラス成分に加え、約10〜20重
量%のLa2O3及び約7重量%以下のTa2O5を含有
している。この組成物において、La2O3は主要な
X線吸収性化合物であり、酸化タンタルは酸化ジ
ルコニウムと共に成核剤として作用する。
更に、米国特許第3801344号は他の放射線不透
過性形成性酸化物、例えば酸化ストロンチウムま
たは酸化ランタン及びランタニド族系列、原子番
号第57〜71番の他の希土類の酸化物、例えば酸化
サマリウム、酸化ジスプロシウム及び酸化テルビ
ウムが使用できること及びところが酸化ランタン
は一般に、酸化プラセオジムと同じく歯充填また
は陶歯組成物に望ましくない色を与えることを示
唆している。この点に関し、該特許第3欄第55行
から第4欄第2行を参照ありたい。
上述した、各種のガラスに関連するこれらの解
決法は全て以下記載する組成物とは異なる。この
ようなガラスの製造は困難かつ高価であり、樹脂
の反射率に合せるという点で問題を呈する。
本発明において、高原子量X線吸収性希土類元
素の量は酸化トリウム(ThO2)を、シリカ、ガ
ラス等のような無機粒子充填剤組成物中の実質的
に唯一のX線吸収性成分として用いることにより
実質的に低下させると同時に歯科用途または他の
放射線不透過性が望まれる目的に用いるため、充
填剤含有重合体樹脂組成物に要求される必要な全
ての特性を与えることができることが見出され
た。
X線造影剤液においてトリウムのX線吸収能力
を用いることは従来知られていた。例えば、米国
特許第1918884号(R.Zellman)はX線写真にお
ける造影剤として用いるための二酸化トリウムゾ
ルを記載している。米国特許第2065718号(T.
Menees及びJ.Miller)は水酸化トリウムの水性
懸濁液を用いており、また米国特許第3368944号
(S.Sandmark及びE.Hagstam)はX線吸収剤が
酸化トリウムでもよい密度0.8〜1.1のX線造影剤
を記載している。
しかしながら、本発明者らは今まで酸化トリウ
ム単独が歯科用充填剤組成物中のX線吸収性成分
として提案されたり用いられたことはないと確信
する。本発明の組成物は歯補修複合材料において
望ましい機械的性質及びその他の物理的性質を保
持する。
従つて、本発明の目的は本質的に無色または透
明であり、微細形態で利用でき、水中または口腔
内環境中で実質的に完全に不溶性である。高いX
線吸収能力のある少割合の少なくとも1種の成分
を含有する歯補綴複合材中に用いるのに適した充
填剤組成物を提供することである。
また、通常の重合性樹脂結合剤、そのための触
媒及び結合剤とカツプリングできる微細無機充填
剤から歯補綴複合材を与えることも本発明の主要
目的である。複合材は歯科診断で用いられるよう
な短波長のX線放射線の高い吸収を示し、比較的
低い熱膨張率を有し、低い毒性、高い機械的強度
及び歯のホウロウ質に合つた光学的半透明性を有
する。
本発明の上記の及び他の目的は液体重合性有機
樹脂結合剤及び微細不活性無機充填剤粒子から形
成されたタイプの、充填剤粒子の実質的に唯一の
X線吸収性成分として全充填剤の約3〜10重量%
の酸化トリウム(ThO2)もしくは酸化トリウム
(ThO2)と酸化タンタル(Ta2O5)との混合物を
用いた放射線不透過性歯補綴複合材組成物により
提供される。
従つて、本発明は重合性樹脂結合剤、結合剤の
ための触媒及び不溶性が非滲出性であり、機械的
に複合材を弱くせず、そして酸化トリウム、及び
酸化トリウムと酸化タンタルとの混合物から選択
された少量の強X線吸収性酸化物を含有する微細
無機充填剤を含有する歯補綴材として特に有用な
放射線不透過性複合材を提供する。充填剤材料は
バリウム等のような可溶性または滲出性成分を実
質的に含有していない。
以下、本発明の好ましい実施態様について説明
する。
複合材の充填剤成分の主要部分は例えば無定形
シリカ、溶融シリカ、水晶、晶質シリカ、ソーダ
ガラスビーズ、セラミツク酸化物、粒状シリケー
トガラスまたは合成晶質材料、例えばβ―ユーク
リプタイト(LiAlSiO4)のような実質的に任意
の珪酸質充填剤粒子材料であつてよい。
酸化トリウム単独、またはこれら酸化物両者の
混合物は、そのままで無機珪酸質充填剤に添加さ
れ、手動式や機械的混合機を含む任意の好適な配
合技術により簡単に均一に混合される。
充填剤組成物は例えば325メツシユ篩を通過で
きる微細粒状形態である。好ましくは、充填剤粒
子の平均直径は約30ミクロン以下、より好ましく
は約2〜5ミクロン以下である。
約35%以上のバリウムガラスを含有する、バリ
ウムガラスを用いた従来の放射線不透過性充填剤
組成物と異なり、本発明に用いる充填剤では約10
重量以下という少量のトリウムの酸化物を含有す
ることが必要であるにすぎない。このことは実質
的な経済的利点を表わす。これは、少なくとも一
部は、バリウムに比較してトリウム及びタンタル
の放射線不透過性が高いことが重量基準で後2者
元素の酸化物を酸化バリウムより効果的にするた
めである。例えば、X線の不透過性という点で
0.497部のTa2O5及び0.236部のThO2が1部の
BaOに等価である。例えば、X線の吸収能力に
関し1gのトリウムが約4.3gのバリウムと等価
であることが発見された。これは、酸化トリウム
(ThO2)ガラス1g当り13.1gのバリウムガラス
(バリウム32重量%)及びTa2O51g当り7.9gの
バリウムガラスに相当する。
従つて、本発明に用いられるX線不透過性組成
物は約3重量%という少ない酸化トリウムを含有
するだけでよく、好ましい範囲はこれが唯一のX
線吸収性成分として用いられる場合は約3〜5重
量%の酸化トリウムである。
X線吸収性酸化物を含有する充填剤組成物は任
意の適当な割合で、例えば約20〜80重量部の充填
剤対約80〜20重量部の有機重合体結合剤という割
合で、有機重合体結合剤と配合される。しかしな
がら、より充填率の高い組成物が歯補綴の組成物
に特に有用である。結合剤系中の充填剤と重合性
及び他の反応性単量体との重量比は好ましくは約
1:1から約6:1であり、特に3:1から約
5:1である。最適には充填剤は充填剤と結合剤
の総量の約65〜85重量%を占める。
有機重合性単量体は広く選択できるが、特に歯
補綴物の目的には通常BIS―O―MAと呼ばれる
2,2―プロパンビス〔3(4―フエノキシ)―
1,2―ヒドロキシプロパン―1―メタクリレー
ト〕のようなジメタクリレート類を他のジメタク
リレート類と混合したものが好ましい。好適な樹
脂材料は、例えば上述したJerucic,Muller,
Rockett,Rogers,Dietzらによる米国特許並び
に米国特許第3066112号及び同第3179623号(いず
れもBowen)及び米国特許第4032504号(H,
Lee,Jr.他)に記載されている。酸化タンタル及
び/または酸化トリウムX線吸収性充填剤粒子が
使用できる他の適当な系は例えば米国特許第
3539533号(Johnson and Johnson)、同第
3709866号(Dentsply Int.)、同第3730947号、同
第3751399号、同第3766132号、同第3774305号
(以上Lec Pharmaceuticals)、同第3835090号、
同第3845009号、同第3853962号(以上Johnson
and Johnson)、同第3860556号(3M Co.)及び
同第3991008号(Temin)に記載されている。
本発明の複合材樹脂組成物は重合性単量体及び
他の反応性単量体(結合剤の粘度を加工可能なペ
ーストまで下げるための「反応性希釈剤」と応々
にして呼ばれる)、触媒すなわち開始剤及び促進
剤すなわち活性剤(触媒と促進剤が反応して重合
反応を触媒する遊離ラジカルを生成する)及び微
細無機充填剤を含有する液体樹脂結合剤系からな
る。結合剤系はまた未重合複合材樹脂組成物を保
存寿命を高めるための安定剤及びUV吸収剤も含
有する。複合材は例えば上記成分の各々を任意の
通常の方法で、好ましくは充填剤をやはりこの分
野でよく知られた方法で好適なシランカツプリン
グ剤で処理した後、混合することにより製造でき
る。好適なカツプリング剤の例には例えばビニル
トリクロルシラン、トリス(2―メトキシエトキ
シ)シラン、トリス(アセトキシ)ビニルシラ
ン、1―N―(ビニルベンジルアミノエチル)ア
ミノプロピルトリメトキシシラン―3,3―メタ
クリルオキシプロピルトリメトキシシラン等が含
まれる。シランカツプリング剤はまた無機粒状充
填剤の添加前に重合性樹脂結合剤に添加できる。
更に、成分はいずれも残りの成分の添加前に予め
混合することができる。複合材を使用する直前ま
で触媒及び重合性樹脂結合剤を分離状態に保つて
おくことが好ましい。これらの技術は全てこの分
野でよく知られており、それ自身で本発明の何ら
一部も構成しない。特定の包装系は例えば米国特
許第3926906号(Lec,Jr.他)に開示されている。
本発明の歯補綴複合材組成物は約20〜50重量部
の重合性単量体及び他の光学的反応性単量体、重
合性及び反応性単量体に対し各々約0.1〜3.0重量
%の触媒、約0.1〜2.0重量%の促進剤、及び約0
〜5重量%、好ましくは約1〜4重量%のシラン
カツプリング剤、及び約20〜80重量部、好ましく
は約50〜80重量部の微細充填剤組成物を含有し、
この充填剤組成物は約3〜10重量%の酸化トリウ
ム(ThO2)または酸化トリウム(ThO2)及び
酸化タンタル(Ta2O5)、好ましくは約3〜7重
量%の酸化トリウム(ThO2)または約3〜5重
量%の酸化トリウム(ThO2)及び約1〜7重量
%の酸化タンタル(Ta2O5)を含有している。
複合材組成物はまた他の成分、例えば重合抑制
剤、安定剤、UV吸収剤も含有でき、これらの性
質及び量は当然重合性樹脂結合剤の性質及び量に
よつて異なり、またこの組成物は顔料または染
料、例えば酸化鉄、カドミニウムイエロー及びオ
レンジ、螢光性酸化亜鉛、二酸化チタン等も、硬
化した複合材において、これが使われる対象の歯
のホウロウ質の本当の色に一層近ずけるために必
要な量で含有できる。
以下、本発明を実施例により説明するが、これ
らは例示的であり、本発明を制限するものではな
い。
実施例 1
本発明の放射線不透過性歯科用複合材の溶出の
速度及び量をバリウム含有ガラス充填剤を用いた
従来の放射線不透過性歯科用複合材の場合と比較
するため、ガラス試料を(a)酢酸アンモニウムでPH
7に緩衝調整した水中及び(b)蒸留水中で撹拌し
た。1時間後、水相を除去し、新しい水相に変え
た。得られた水溶液を、硬化した複合材を取出し
た後、Perkin―Elmer Model 306AA装置を用
いた原子吸光分析にかけた。
下記の結果が得られた。
The present invention relates to radiopaque filler compositions and, in particular, to dental prosthetic compositions using such radiopaque filler compositions. Particulate reinforced polymer matrix composites are widely used as dental prosthetics, especially fillings and incisal edge repairs, inlays, etc. The inorganic filler phase is typically a siliceous material,
Examples include silica, quartz, refractory salts, glass or ceramic materials. Although these reinforced polymeric materials give acceptable results with respect to strength, coloration, non-toxicity and coefficient of thermal expansion, these materials are difficult to distinguish by X-ray analysis such as those used in dental diagnostics. suffers from this drawback. Therefore, many attempts have been made to obtain radiopaque dental compositions in which barium-containing glasses are used to replace some or all of the siliceous fillers. An example is US Pat. No. 3,808,170 (S.
Rogers), U.S. Patent No. 3801344, U.S. Patent No. 3826778
No. 3,911,581 (both E. Dietz) and US Pat. No. 4,032,504 (Lee Rharmaceuticals). However, glass fillers formulated to contain sufficient barium to achieve sufficient radiopacity may be difficult to achieve since the glass is fairly soluble in aqueous environments, particularly in the oral environment, and barium ions are leached from the glass. It suffers from the disadvantage of doing so.
There is very strong evidence that this form of barium presents a toxicity risk. Recently attempts have been made to replace barium glass with other radiopaque filler materials. These attempts have included, for example, the use of fairly insoluble barium salts such as barium carbonate and barium sulfate in combination with siliceous fillers. However, these reinforced ceramic materials were unsatisfactory in terms of the mechanical strength of the resulting composites. U.S. Pat. No. 3,959,212 (Rockett et al.) discloses the use of microcrystalline barium-containing silicates and, in particular, calcium barium silicate in crystalline form, a polymerizable binder, a catalyst system for polymerizing the binder, and at least a portion of which is radiopaque. The present invention teaches use in direct-fill dental composites containing finely divided inorganic fillers formed from crystalline calcium barium silicate. Although this composition provides some improvement with respect to the solubility of the barium component of the inorganic filler, it is not completely satisfactory with regard to the leaching properties of the barium component and the radiopacity of the composite material. Also, for example, US Pat. No. 3,971,754 (A.
Jurecic) and U.S. Pat. No. 3,973,972 and U.S. Pat.
No. 4017454 (both by G. Muller), it was proposed to utilize the high X-ray absorption ability of high atomic weight atoms. For example, U.S. Pat. No. 3,971,754 discloses ceramic filler compositions using X-ray absorbing atoms selected from lanthus in oxide, carbonate or fluoride form, strontium, and hafnium with minor additions to tantalum. teaching. According to this patent, the compound of X-ray absorbing atoms accounts for about 5-60% of the total molten glass composition, preferably 25-40%.
This composition is then incorporated into the repair matrix. U.S. Pat. No. 3,973,972 and U.S. Pat. No. 4,017,454 disclose transparent, colorless glass-ceramics with low expansion coefficients, high X-ray absorption capabilities, and suitable for use in dental filling compositions; The composition mainly consists of SiO 2 , Al 2 O 3 , Li 2 O, P 2 O 5 and
In addition to the other glass components which are ZrO2 , it contains about 10-20% by weight La2O3 and up to about 7 % Ta2O5 . In this composition, La 2 O 3 is the main X-ray absorbing compound and tantalum oxide acts as a nucleating agent together with zirconium oxide. Additionally, U.S. Pat. No. 3,801,344 discloses the use of other radiopaque-forming oxides, such as strontium oxide or lanthanum oxide, and oxides of other rare earths of the lanthanide series, atomic numbers 57-71, such as samarium oxide, lanthanum oxide, etc. It has been suggested that dysprosium and terbium oxide can be used, although lanthanum oxide, like praseodymium oxide, generally imparts an undesirable color to tooth filling or porcelain compositions. In this regard, please refer to column 3, line 55 to column 4, line 2 of the patent. All of these solutions related to the various glasses mentioned above are different from the compositions described below. Manufacturing such glasses is difficult and expensive, and presents problems in matching the reflectance of the resin. In the present invention, the amount of high atomic weight X-ray absorbing rare earth elements is such that thorium oxide ( ThO2 ) is used as substantially the only X-ray absorbing component in an inorganic particle filler composition such as silica, glass, etc. It has been found that this can provide all the necessary properties required of a filled polymeric resin composition for use in dental applications or other purposes where radiopacity is desired while at the same time substantially reducing radiopacity. Served. It has been known in the past to use the X-ray absorption ability of thorium in X-ray contrast agent liquids. For example, US Pat. No. 1,918,884 (R. Zellman) describes thorium dioxide sols for use as contrast agents in radiography. U.S. Patent No. 2065718 (T.
Menees and J. Miller) used an aqueous suspension of thorium hydroxide, and US Pat. No. 3,368,944 (S. Sandmark and E. Hagstam) reported that the Describes X-ray contrast agents. However, the inventors believe that thorium oxide alone has never been proposed or used as an X-ray absorbing component in dental filler compositions. The compositions of the present invention retain desirable mechanical and other physical properties in tooth repair composites. Accordingly, objects of the present invention are essentially colorless or transparent, available in microscopic form, and substantially completely insoluble in water or the oral environment. high x
It is an object of the present invention to provide filler compositions suitable for use in dental prosthetic composites containing a small proportion of at least one component capable of absorbing radiation. It is also a main object of the present invention to provide dental prosthetic composites from finely divided inorganic fillers that can be coupled with conventional polymeric resin binders, catalysts and binders therefor. Composites exhibit high absorption of short-wavelength X-ray radiation, such as those used in dental diagnostics, have a relatively low coefficient of thermal expansion, low toxicity, high mechanical strength, and an optical semicontrast that matches the porosity of the tooth. Has transparency. These and other objects of the present invention are of the type formed from a liquid polymerizable organic resin binder and finely divided inert inorganic filler particles; Approximately 3 to 10% by weight of
of thorium oxide (ThO 2 ) or a mixture of thorium oxide (ThO 2 ) and tantalum oxide (Ta 2 O 5 ). Accordingly, the present invention provides a polymeric resin binder, a catalyst for the binder and an insoluble material which is non-leaching and does not mechanically weaken the composite, and which uses thorium oxide and mixtures of thorium oxide and tantalum oxide. A radiopaque composite material particularly useful as a dental prosthetic material is provided, which contains a fine inorganic filler containing a small amount of a strong X-ray absorbing oxide selected from the following. The filler material is substantially free of soluble or exudable components such as barium and the like. Preferred embodiments of the present invention will be described below. The main part of the filler component of the composite is, for example, amorphous silica, fused silica, quartz, crystalline silica, soda glass beads, ceramic oxides, granular silicate glasses or synthetic crystalline materials, such as β-eucryptite (LiAlSiO 4 ) may be virtually any siliceous filler particle material, such as. Thorium oxide alone, or a mixture of both oxides, can be added neat to the inorganic siliceous filler and easily mixed uniformly by any suitable compounding technique, including manual or mechanical mixers. The filler composition is in finely divided form that can pass through a 325 mesh screen, for example. Preferably, the filler particles have an average diameter of about 30 microns or less, more preferably about 2-5 microns or less. Unlike conventional radiopaque filler compositions using barium glass, which contain about 35% or more barium glass, the filler used in the present invention contains about 10% or more barium glass.
It is only necessary to contain a small amount of thorium oxide, by weight or less. This represents a substantial economic advantage. This is at least in part because the increased radiopacity of thorium and tantalum compared to barium makes oxides of the latter two elements more effective than barium oxide on a weight basis. For example, in terms of X-ray opacity
0.497 parts Ta 2 O 5 and 0.236 parts ThO 2 in 1 part
Equivalent to BaO. For example, it has been discovered that 1 gram of thorium is equivalent to approximately 4.3 grams of barium in terms of its ability to absorb X-rays. This corresponds to 13.1 g of barium glass (32% barium by weight) per g of thorium oxide (ThO 2 ) glass and 7.9 g of barium glass per g of Ta 2 O 5 . Therefore, the radiopaque compositions used in the present invention need only contain as little as about 3% by weight of thorium oxide, with the preferred range being that this is the only
When used as the line-absorbing component, it is about 3-5% by weight thorium oxide. Filler compositions containing the Combined with a coalescing binder. However, compositions with higher filling rates are particularly useful in dental prosthetic compositions. The weight ratio of filler to polymerizable and other reactive monomers in the binder system is preferably from about 1:1 to about 6:1, particularly from 3:1 to about 5:1. Optimally, the filler comprises about 65-85% by weight of the total filler and binder. There is a wide range of organic polymerizable monomers to choose from, but for dental prosthesis purposes in particular 2,2-propane bis[3(4-phenoxy)-], commonly referred to as BIS-O-MA,
Preferably, dimethacrylates such as 1,2-hydroxypropane-1-methacrylate are mixed with other dimethacrylates. Suitable resin materials include, for example, Jercic, Muller,
U.S. patents by Rockett, Rogers, Dietz et al., as well as U.S. Pat.
Lee, Jr. et al.). Other suitable systems in which tantalum oxide and/or thorium oxide X-ray absorbing filler particles can be used are e.g.
No. 3539533 (Johnson and Johnson), same no.
No. 3709866 (Dentsply Int.), No. 3730947, No. 3751399, No. 3766132, No. 3774305 (Lec Pharmaceuticals), No. 3835090,
No. 3845009, No. 3853962 (Johnson
and Johnson), No. 3860556 (3M Co.) and No. 3991008 (Temin). The composite resin compositions of the present invention contain polymerizable monomers and other reactive monomers (sometimes referred to as "reactive diluents" to reduce the viscosity of the binder to a processable paste); It consists of a liquid resin binder system containing a catalyst or initiator and a promoter or activator (the catalyst and promoter react to form free radicals that catalyze the polymerization reaction) and a finely divided inorganic filler. The binder system also contains stabilizers and UV absorbers to enhance the shelf life of the unpolymerized composite resin composition. The composite can be made, for example, by mixing each of the above components in any conventional manner, preferably after treating the filler with a suitable silane coupling agent, also in a manner well known in the art. Examples of suitable coupling agents include, for example, vinyltrichlorosilane, tris(2-methoxyethoxy)silane, tris(acetoxy)vinylsilane, 1-N-(vinylbenzylaminoethyl)aminopropyltrimethoxysilane-3,3-methacryloxy Includes propyltrimethoxysilane, etc. A silane coupling agent can also be added to the polymeric resin binder prior to addition of the inorganic particulate filler.
Additionally, any of the ingredients can be premixed prior to addition of the remaining ingredients. It is preferred to keep the catalyst and polymeric resin binder separated until just before using the composite. All of these techniques are well known in the art and do not themselves form any part of the present invention. Particular packaging systems are disclosed, for example, in US Pat. No. 3,926,906 (Lec, Jr. et al.). The dental prosthetic composite composition of the present invention comprises about 20 to 50 parts by weight of polymerizable monomer and other optically reactive monomers, about 0.1 to 3.0% by weight each of polymerizable and reactive monomers. of catalyst, about 0.1-2.0% by weight promoter, and about 0
~5% by weight, preferably about 1-4% by weight of a silane coupling agent, and about 20-80 parts by weight, preferably about 50-80 parts by weight of a fine filler composition;
The filler composition contains about 3-10% by weight thorium oxide ( ThO2 ) or thorium oxide ( ThO2 ) and tantalum oxide ( Ta2O5 ), preferably about 3-7% by weight thorium oxide (ThO2 ) . ) or about 3-5% by weight thorium oxide ( ThO2 ) and about 1-7% by weight tantalum oxide ( Ta2O5 ). The composite composition may also contain other ingredients, such as polymerization inhibitors, stabilizers, UV absorbers, the nature and amount of which will of course depend on the nature and amount of the polymeric resin binder and the composition. Pigments or dyes, such as iron oxide, cadmium yellow and orange, fluorescent zinc oxide, titanium dioxide, etc., are also used in the cured composite to more closely match the true color of the enamel of the tooth for which it is used. It can be contained in the required amount. EXAMPLES The present invention will be explained below with reference to Examples, but these are illustrative and do not limit the present invention. Example 1 To compare the rate and amount of elution of the radiopaque dental composite of the present invention with that of a conventional radiopaque dental composite using a barium-containing glass filler, a glass sample was a) PH with ammonium acetate
(b) in distilled water and (b) in distilled water. After 1 hour, the aqueous phase was removed and replaced with fresh aqueous phase. The resulting aqueous solution was subjected to atomic absorption spectrometry using a Perkin-Elmer Model 306AA instrument after removing the cured composite. The following results were obtained.
【表】【table】
【表】【table】
【表】
実施例 2
最初はPH7に緩衝調整した水(水1000g当り1
gの酢酸アンモニウム)中でKimble′s Ray―
Sorb T―2000を同様に滲出させたところ、PHが
9.5まで上昇し、1時間で500ppmを越すバリウム
が滲出した。
実施例 3
2.4gのThO2(アメリカ合衆国ニユージヤージ
ー州Phillipsburg.J.T.Baker Chemical Co.から
入手。粒径325メツシユ)及び76.4gのIMSIL A
―10(Illinois Minerals Co.から得た粒径10ミク
ロン未満の無定形シリカ)を混合することにより
放射線不透過性複合材樹脂用充填剤を製造した。
混合物は歯に合う着色を達成する少量の(0.001
g未満)の顔料を含有していた。この充填剤は電
動式乳鉢及び乳棒を用いて、12.5gのBIS―
GMA(Frecman Chemical Co.から購入)、12.5
gのヘキサメチレンジメタクリレート
(Sartomer Resins Co.から購入)及び1.2gのγ
―メタクリロイルオキシプロピルトリメトキシシ
ランからなる26.2gの混合物と充分混合した。得
られたペーストを二等分し、一方に単量体重量の
4%のクメンヒドロペルオキシドを添加し、他方
に単量体重量の2%のアセチルチオ尿素
(Eastwan Chemicals Co.から購入)を添加し
た。2種のペーストの数個の小さな部分に等分
し、スパチユウで充分で混合し、混合物をテフロ
ン(Teflon)金型内に入れて圧縮強さ測定用の
円筒を製造した。試験(Instron機)は硬化され
た複合材試験が約3164Kg/cm2(45.000psi)の平
均圧縮強さを有していることを示した。
市販の歯科用X線装置を用いたX線試験は
ThO2含有複合材は50重量%無定形シリカ及び50
重量%Corning7724バリウムガラスからなる複合
材に匹敵するX線透過性を有していることを示し
た。[Table] Example 2 Initially, water buffered to pH 7 (1000 g of water
Kimble's Ray in g of ammonium acetate)
When Sorb T-2000 was leached in the same way, the PH was
The temperature rose to 9.5, and more than 500 ppm of barium oozed out in one hour. Example 3 2.4 g ThO 2 (obtained from JTBaker Chemical Co., Phillipsburg, New Jersey, USA, particle size 325 mesh) and 76.4 g IMSIL A
-10 (amorphous silica with a particle size less than 10 microns obtained from Illinois Minerals Co.) was prepared as a filler for radiopaque composite resins.
The mixture is mixed with a small amount (0.001
gram) of pigment. Using an electric mortar and pestle, apply 12.5 g of BIS-
GMA (purchased from Frecman Chemical Co.), 12.5
g of hexamethylene dimethacrylate (purchased from Sartomer Resins Co.) and 1.2 g of γ
- Thoroughly mixed with 26.2 g of a mixture consisting of methacryloyloxypropyltrimethoxysilane. The resulting paste was divided into two equal parts and 4% of the monomer weight of cumene hydroperoxide was added to one and 2% of the monomer weight of acetylthiourea (purchased from Eastwan Chemicals Co.) was added to the other. . The two pastes were divided into several small portions, thoroughly mixed with a spatula, and the mixture was placed in a Teflon mold to produce a cylinder for compressive strength measurements. Testing (Instron machine) showed that the cured composite test had an average compressive strength of about 3164 Kg/cm 2 (45.000 psi). X-ray tests using commercially available dental X-ray equipment
The ThO2- containing composite contains 50% by weight amorphous silica and 50%
It was shown to have X-ray transparency comparable to a composite material made of % Corning 7724 barium glass by weight.
Claims (1)
無機放射線不透過性充填剤粒子から製造されるタ
イプの放射線不透過性歯補綴複合材組成物におい
て、 放射線不透過性充填剤粒子の実質的に唯一のX
線吸収成分として全充填剤の約3〜10重量%の酸
化トリウム(ThO2)または酸化トリウム
(ThO2)と五酸化タンタル(Ta2O5)との混合物
を使用していることを特徴とする組成物。 2 放射線不透過性充填剤粒子が95〜97重量%の
珪酸質またはセラミツク充填剤粒子および3〜5
重量%の酸化トリウムからなる、特許請求の範囲
第1項記載の複合材組成物。 3 放射線不透過性充填剤粒子が90〜96重量%の
珪酸質またはセラミツク充填剤粒子および3〜5
重量%の酸化トリウムおよび1〜7重量%の五酸
化タンタルからなる、特許請求の範囲第1項記載
の複合材組成物。 4 含水環境中で不活性かつ非滲出性であり、実
質的に無色または半透明である、特許請求の範囲
第1項記載の組成物。Claims: 1. A radiopaque dental prosthetic composite composition of the type made from a liquid polymerizable organic resin binder and fine inert inorganic radiopaque filler particles, comprising: a radiopaque filler; Substantially the only X of the particle
It is characterized by using thorium oxide (ThO 2 ) or a mixture of thorium oxide (ThO 2 ) and tantalum pentoxide (Ta 2 O 5 ) in an amount of about 3 to 10% by weight of the total filler as a line-absorbing component. composition. 2 siliceous or ceramic filler particles containing 95 to 97% by weight of radiopaque filler particles; and 3 to 5
A composite composition according to claim 1, comprising % by weight of thorium oxide. 3 siliceous or ceramic filler particles containing 90 to 96% by weight of radiopaque filler particles and 3 to 5
A composite composition according to claim 1, comprising thorium oxide in weight percent and tantalum pentoxide in a range of 1 to 7 weight percent. 4. The composition of claim 1, which is inert and non-leaching in an aqueous environment and is substantially colorless or translucent.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP12521479A JPS5651407A (en) | 1979-09-28 | 1979-09-28 | Radiation impermeable dental composition |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP12521479A JPS5651407A (en) | 1979-09-28 | 1979-09-28 | Radiation impermeable dental composition |
Publications (2)
Publication Number | Publication Date |
---|---|
JPS5651407A JPS5651407A (en) | 1981-05-09 |
JPH027922B2 true JPH027922B2 (en) | 1990-02-21 |
Family
ID=14904689
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP12521479A Granted JPS5651407A (en) | 1979-09-28 | 1979-09-28 | Radiation impermeable dental composition |
Country Status (1)
Country | Link |
---|---|
JP (1) | JPS5651407A (en) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3039664C2 (en) * | 1980-10-21 | 1986-07-17 | Kulzer & Co Gmbh, 6380 Bad Homburg | Radiopaque dental material with filler based on silicate |
US4503169A (en) * | 1984-04-19 | 1985-03-05 | Minnesota Mining And Manufacturing Company | Radiopaque, low visual opacity dental composites containing non-vitreous microparticles |
WO2023042598A1 (en) * | 2021-09-14 | 2023-03-23 | 株式会社トクヤマデンタル | X-ray opaque filler material, x-ray opaque dental filler material, method for producing x-ray opaque filler material, and curable dental composition |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS5090650A (en) * | 1973-12-10 | 1975-07-19 | ||
JPS5133117A (en) * | 1973-09-21 | 1976-03-22 | Jenaer Glaswerk Schott & Gen |
-
1979
- 1979-09-28 JP JP12521479A patent/JPS5651407A/en active Granted
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS5133117A (en) * | 1973-09-21 | 1976-03-22 | Jenaer Glaswerk Schott & Gen | |
JPS5090650A (en) * | 1973-12-10 | 1975-07-19 |
Also Published As
Publication number | Publication date |
---|---|
JPS5651407A (en) | 1981-05-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US4375967A (en) | Dental composition containing X-ray opaque material | |
US5304586A (en) | Radiopaque fluoride releasing VLC dental composites and the use of specific fillers therein | |
JP4851454B2 (en) | Dental composition containing nano-zirconia filler | |
EP1246859B1 (en) | Polymerizable dental compositions based on epoxies that contain silicon | |
CA2051333C (en) | Polymerizable dental material | |
US4220582A (en) | Dental restorative compositions of improved X-ray opacity | |
US4350532A (en) | Glass composition and articles | |
US5354785A (en) | Polymerizable dental materials | |
US4500657A (en) | Dental restorative compositions having improved mechanical properties and hydrolytic stability | |
USRE32073E (en) | Dental filling composition utilizing zinc-containing inorganic filler | |
JP2007538072A (en) | Use of nanoparticles to adjust the refractive index of dental compositions | |
JP2007538071A (en) | Dental compositions containing nanofillers and related methods | |
AU2004305250A1 (en) | Glass filler material and method of production | |
US4358549A (en) | Dental filling composition utilizing zinc-containing inorganic filler | |
JPS6347682B2 (en) | ||
CN114767549B (en) | Photochromic dental composite material and preparation method thereof | |
EP0102199B1 (en) | Dental restorative compositions having improved mechanical properties and hydrolytic stability | |
JPH027922B2 (en) | ||
US4188317A (en) | Dental restorative compositions containing titanium silicate | |
USRE32299E (en) | Glass composition and articles | |
GB2064550A (en) | Radio-opaque dental restorative compositions | |
CA1134527A (en) | Radio-opaque dental compositions | |
SE436245B (en) | X-ray absorbent composite composition for restoring teeth, and particulate filler material designed for this | |
CA1157892A (en) | Zinc-containing glass composition | |
GB2058088A (en) | Filler for dental restorative compositions |